Pharma & Biotech

Kodiak Sciences Inc. witnessed a dramatic trading session as its stock soared more than 11% to reach $21.05. The biotechnology...

Thermo Fisher Scientific delivered a powerful third-quarter 2025 performance that exceeded market expectations, creating an intriguing investment narrative as the...

This week represents a critical juncture for Teva Pharmaceutical, with two significant events poised to influence the company's stock trajectory....

Eli Lilly is currently redefining pharmaceutical success through its revolutionary weight-loss medications, propelling the company into unprecedented territory. The pharmaceutical...

Olema Pharmaceuticals has scheduled a critical presentation for December, where the biotechnology firm will unveil progress from its OPERA-02 Phase...

The investment community is closely monitoring Hologic shares following a significant acquisition proposal. With private equity heavyweights making their move...

Investors in BioNTech are bracing for a pivotal moment as the biotechnology firm prepares to release its quarterly financial results....

CareDx shares are approaching a pivotal moment as the company navigates significant leadership changes and regulatory advancements. With fresh medical...

The Schwab U.S. Dividend Equity ETF™ is confronting persistent investor outflows as market sentiment shifts away from high-dividend strategies. Despite...

Assembly Biosciences has captured market attention with remarkable clinical trial results that propelled its shares upward by more than 25%...